| |
|
|
| |
03/10/2010
New Hope To Vitiligo Patients Offered By Skin Transplant
In the first study of its kind in the United States, Henry Ford Hospital showed that skin transplant surgery is safe and effective for treating vitiligo. Henry Ford researchers followed 23 patients for up to six months after surgery and found that the treated area regained on average 52 percent of its natural skin color...
more info
|
03/10/2010
Graceway Announces Journal Of The American Academy Of Dermatology Publishes Articles On New Short-Course Imiquimod Formulation In Actinic Keratosis
The Journal of the American Academy of Dermatology (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses - 2.5% and 3.75% - administered daily on either 2-week or 3-week treatment cycles. While all study arms met the primary endpoint of complete clearance versus placebo, data suggest that, of the regimens studied, imiquimod 3...
more info
|
03/07/2010
Johnson & Johnson Consumer Companies, Inc., Unveils CYTOMIMICâ„¢ Technology At 68th Annual Meeting Of The American Academy Of Dermatology
Building on decades of research into how the body's electrical field affects skin regeneration, scientists at Johnson & Johnson Consumer Companies, Inc., have discovered how to harness the power of bioelectricity to help improve skin rejuvenation...
more info
|
03/07/2010
What Is Heat Rash? What Is Prickly Heat? What Causes Heat Rash?
Heat rash, also known as prickly heat, sweat rash and miliaria, is an itchy, red skin rash that often causes a stinging or prickling sensation. It is common in infants but can affect adults too, especially during hot, humid weather. Heat rash develops when sweat ducts become blocked and perspiration is trapped under the skin. This causes irritation and results in the rash...
more info
|
03/06/2010
COPPERTONE(R) Solar Research Center Unveils Studies On Efficacy Of Topical Antioxidants In Sunscreens At 2010 Annual Meeting
Schering-Plough HealthCare Products, Inc., the consumer healthcare division of Merck & Co., Inc., the makers of COPPERTONE®, announced at the 2010 Annual Meeting of the American Academy of Dermatology the results of studies demonstrating the efficacy of topical antioxidants in broad spectrum sunscreens...
more info
|
|
|
|
|